146 related articles for article (PubMed ID: 25205106)
21. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
[TBL] [Abstract][Full Text] [Related]
22. Cortactin expression: Association with disease progression and survival in oral squamous cell carcinoma.
Horn D; Gross M; Dyckhoff G; Fuchs J; Grabe N; Weichert W; Herpel E; Herold-Mende C; Lichter P; Hoffmann J; Hess J; Freier K
Head Neck; 2018 Dec; 40(12):2685-2694. PubMed ID: 30456890
[TBL] [Abstract][Full Text] [Related]
23. Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma.
Hsu KF; Lin CK; Yu CP; Tzao C; Lee SC; Lee YY; Tsai WC; Jin JS
Dis Esophagus; 2009; 22(5):402-8. PubMed ID: 19207554
[TBL] [Abstract][Full Text] [Related]
24. microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS.
Zhu L; Wang Z; Fan Q; Wang R; Sun Y
Oncol Rep; 2014 Jan; 31(1):280-6. PubMed ID: 24154848
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
Zhao Y; Ma K; Yang S; Zhang X; Wang F; Zhang X; Liu H; Fan Q
Int J Oncol; 2018 Aug; 53(2):644-658. PubMed ID: 29767234
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Liu Z; Yang T; Xu Z; Cao X
Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379
[TBL] [Abstract][Full Text] [Related]
27. Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy.
Sun ZG; Wang Z; Zhang M
Asia Pac J Clin Oncol; 2012 Dec; 8(4):e68-76. PubMed ID: 22897688
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs in esophageal squamous cell carcinoma: Potential biomarkers and therapeutic targets.
Mei LL; Qiu YT; Zhang B; Shi ZZ
Cancer Biomark; 2017; 19(1):1-9. PubMed ID: 28269750
[TBL] [Abstract][Full Text] [Related]
29. [Relationship between clinicopathologic characteristics and expression of VEGF-C and VEGF-D in esophageal squamous cancer].
Jiang M; Gou HF; Yang Y; Cao D; Hou M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):240-4. PubMed ID: 19462898
[TBL] [Abstract][Full Text] [Related]
30. MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma.
Jin L; Yi J; Gao Y; Han S; He Z; Chen L; Song H
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):810-9. PubMed ID: 27563011
[TBL] [Abstract][Full Text] [Related]
31. Amplification and overexpression of
Hu X; Moon JW; Li S; Xu W; Wang X; Liu Y; Lee JY
Int J Med Sci; 2016; 13(11):868-874. PubMed ID: 27877079
[TBL] [Abstract][Full Text] [Related]
32. Original Research: miR-194 inhibits proliferation and invasion and promotes apoptosis by targeting KDM5B in esophageal squamous cell carcinoma cells.
Cui G; Liu D; Li W; Li Y; Liang Y; Shi W; Zhao S
Exp Biol Med (Maywood); 2017 Jan; 242(1):45-52. PubMed ID: 27480251
[TBL] [Abstract][Full Text] [Related]
33. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
34. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.
Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF
Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factors C and D and lymphangiogenesis at the early stage of esophageal squamous cell carcinoma progression.
Kumagai Y; Tachikawa T; Higashi M; Sobajima J; Takahashi A; Amano K; Fukuchi M; Ishibashi K; Mochiki E; Yakabi K; Tamaru J; Ishida H
Dis Esophagus; 2018 Aug; 31(8):. PubMed ID: 29800478
[TBL] [Abstract][Full Text] [Related]
36. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
Sun N; Ye L; Chang T; Li X; Li X
Int J Clin Exp Pathol; 2014; 7(10):6871-9. PubMed ID: 25400770
[TBL] [Abstract][Full Text] [Related]
37. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
39. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
40. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]